NASDAQ
Cerevel Therapeutics Holdings, Inc. (CERE) has a fcf yield of -5.04% as of Friday, May 29, 2026. This represents a 9.33% increase compared to its 12-month average of -5.56%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.